ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,154.42
0.41%
Dow Jones
37,903.29
0.00%
Gold vs US Dollar
2,298.01
-1.13%
Brent Oil
84.30
0.91%
Bitcoin
58,641.34
0.69%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Ipsen SA (IPN) Share Price

IPN Ipsen SA

116.00
1.90 (1.67%)
Last Updated: 12:50:53
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Ipsen SA EU:IPN Euronext Ordinary Share FR0010259150 
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   1.90 1.67 116.00 115.90 116.20 116.30 114.40 115.3 24,017 11:50:53   
 Type  Size  Price  Time  Units 
  5 116.00 11:50:38 EUR
 
Recent News
DateTimeSource
HeadlineMore IPN News
02/05/202406:30GLOBEIpsen appoints Keira Driansky as EVP, President of North America
02/05/202406:30GLOBEIpsen appoints Keira Driansky as EVP, President of North America
02/05/202406:30GLOBEIpsen nomme Keira Driansky, en qualité de Vice-Présidente Exécutive, et Présidente Amérique du Nord
24/04/202406:00GLOBEIpsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance
24/04/202406:00GLOBEIpsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance
24/04/202406:00GLOBEIpsen enregistre une solide croissance de ses ventes au premier trimestre et confirme ses objectifs financiers pour l'exercice 2024
22/04/202406:00GLOBEIpsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases
Period
Draw mode
Data Downloads for IPN

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Ipsen SA Articles